Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
2010-023159-27Phase 3Active
Phase 3 trial of levobupivacaine in postoperative pain, sponsored by MANUEL �NGEL GÓMEZ R�OS. Primary endpoints: Reduction in secondary hyperalgesia area and Chronic postoperative pain. Started Nov 2011; status: active.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on 2010-023159-27.